about
Reduced vasodilator capacity in syndrome X related to structure and function of resistance arteriesBiomedical PhD education--an international perspective.Morphology and function of mesenteric resistance arteries in transgenic rats with low-renin hypertension.Location of resistance arteries.Early narrowed afferent arteriole is a contributor to the development of hypertension.Small artery remodeling in hypertension.Small artery remodeling and significance in the development of hypertension.Mechanisms of relaxations of bovine isolated bronchioles by the nitric oxide donor, GEA 3175Vascular growth in hypertension.Structure of renal afferent arterioles in the pathogenesis of hypertension.Responses to noradrenaline in human subcutaneous resistance arteries are mediated by both alpha 1- and alpha 2-adrenoceptors.Meeting report: highlights of the 8th International Symposium on Resistance Arteries.Combination of Ca2+ -activated K+ channel blockers inhibits acetylcholine-evoked nitric oxide release in rat superior mesenteric artery.An increased calcium sensitivity of mesenteric resistance vessels in young and adult spontaneously hypertensive ratsAbnormalities of the resistance vasculature in hypertension: correction by vasodilator therapy.Involvement of transglutaminase 2 and voltage-gated potassium channels in cystamine vasodilatation in rat mesenteric small arteries.Potential protective properties of a stable, slow-releasing nitric oxide donor, GEA 3175, in the lung.Small artery remodelling in hypertension.Changes to the vascular system resulting from hypertension and their effects on response to therapy.Changes in sodium pump activity and vascular contraction.Nitric oxide, prostanoid and non-NO, non-prostanoid involvement in acetylcholine relaxation of isolated human small arteries.The fourth Sir George Pickering memorial lecture. The structure of the resistance vasculature in essential hypertension.Pathophysiology of vascular smooth muscle in hypertension.Resistance vessel growth and remodelling: cause or consequence in cardiovascular disease.Pathophysiology of smooth muscle in hypertension.Remodeling of resistance vessel structure in essential hypertension.Resistance vessel structure and the pathogenesis of hypertension.Mechanical and other factors involved in vascular injury related to hypertension.Vascular remodelling in hypertension.Control of vascular structure.The Seventh Heymans Memorial Lecture Ghent, February 18, 1995. Physiological aspects of small arteries.Contractile and morphological properties of the portal vein in spontaneously hypertensive and wistar-kyoto rats.Differences in sensitivity of rat mesenteric small arteries to agonists when studied as ring preparations or as cannulated preparationsPinacidil opens K+-selective channels causing hyperpolarization and relaxation of noradrenaline contractions in rat mesenteric resistance vessels.Role of extracellular and intracellular acidosis for hypercapnia-induced inhibition of tension of isolated rat cerebral arteries.Effects of losartan and enalapril on small artery structure in hypertensive rats.Relaxing actions of corticotropin-releasing factor on rat resistance arteries.The superoxide dismutase mimetic, tempol, blunts right ventricular hypertrophy in chronic hypoxic rats.Neuropeptide Y regulates intracellular calcium through different signalling pathways linked to a Y(1)-receptor in rat mesenteric small arteries.Response of vascular smooth muscle to rapid load changes [proceedings]
P50
Q28371305-135D1F31-47DE-4A9C-898C-602127B10110Q30427859-B7318568-CF03-4C23-A84A-11FFBFE34446Q30801596-4438B58A-9AD3-4BBE-9203-2825937B7B06Q34138421-8F27EE1D-EECC-49F7-AD0A-3A62CCAE4F33Q34333627-38D5A00F-F085-400A-93A3-EBEA359624F9Q34492807-BDF905EC-7837-4017-838C-F73463CC9B15Q34647065-20CB7E4E-F543-491E-A717-C7D0E42A8B30Q35027272-58C57C9B-4802-461B-AD8E-685DD1D4E707Q35333056-18FF8FA6-04DE-4498-BDBD-F5A2A7D51796Q35850508-D5BEF020-7B31-4115-A8C8-9DD3939AABC6Q35888019-37A696B9-AA5C-410D-AE8A-D60198B3BBABQ36038039-C7DAEC29-CC1C-48BA-9761-AF8143CC7137Q36054413-3AF9000E-0FAE-4D2D-B92A-C3C37F8813CDQ36097084-84A2CDF3-7D5A-4FEB-949A-B421E85C66BEQ36369572-B49EA903-13C2-4A9A-9504-E8787AAA18EAQ36599656-574B5A69-7AFD-4A2C-9008-9C1ABBA97CEDQ36703836-35AB6EA8-D164-4857-AFEA-4064CD6845EBQ37898187-00973458-B120-4FBB-A147-B8307761EEA7Q38145911-25EB9E0D-FB38-4498-A2DD-4F0ABE0D1DA7Q38155162-ACACCECF-C368-4154-9696-97FECC19D5BBQ38819685-C57A5CFD-D786-47A5-A111-97979BDF04C3Q39663150-6FB1B975-EEB0-46F0-A108-8275FFA018A9Q40205141-15EB8C43-E86C-44D2-8F89-BEB447FB6C2CQ40368403-D40AF165-521F-4BC5-A8E6-FD45E97A8BC8Q40430189-F201B559-AB3E-4783-9CBA-B33C388559A9Q40629395-6C466B6D-25D7-476D-9E57-58453578841DQ40740433-F7C6EC0F-8903-43BD-AA2E-6A7548001878Q40763409-F12A096A-B3A9-46BD-A009-AB7F59647CE2Q40843119-732CCFD5-52F4-4A02-A167-FE6B11B644E5Q40904657-87DB6092-D96D-4850-8F8F-786FB40E4463Q41192611-6EEDAD70-0E5C-458F-82E1-6422BDF787E3Q41644884-83736A0C-21AE-4DC3-88F9-B88F66FC6A80Q41963009-92B920E1-147E-41C9-A178-2D9615DF1623Q42257230-36BF21ED-82FC-4956-98A2-5B866534FCA5Q42488437-247D3527-6BD9-42A6-8825-8A86277EE132Q42540080-309D10FF-91A7-40DC-97E9-000AAE89552AQ42714025-86A39152-4152-4C28-8DC0-40949B90EF27Q42975224-5FC61CE6-44D5-43F6-B02A-66DE9AD6F0E5Q43263791-CECF3299-BA91-4234-AABE-289A088F6AE9Q43552298-67A68A9D-0790-457F-A5A6-2AB741E08C87
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Michael J Mulvany
@ast
Michael J Mulvany
@en
Michael J Mulvany
@es
Michael J Mulvany
@nl
Michael J Mulvany
@sl
type
label
Michael J Mulvany
@ast
Michael J Mulvany
@en
Michael J Mulvany
@es
Michael J Mulvany
@nl
Michael J Mulvany
@sl
prefLabel
Michael J Mulvany
@ast
Michael J Mulvany
@en
Michael J Mulvany
@es
Michael J Mulvany
@nl
Michael J Mulvany
@sl
P106
P21
P31
P496
0000-0002-9206-7899